Literature DB >> 4468849

Metabolism of radio-labelled C3: effects of in vivo activation in rabbits.

J A Charlesworth, D G Williams, P Naish, P J Lachmann, D K Peters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4468849      PMCID： PMC1553954     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  10 in total

1.  ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.

Authors:  C B LAURELL
Journal:  Anal Biochem       Date:  1965-02       Impact factor: 3.365

2.  The theory of tracer experiments with 131I-labelled plasma proteins.

Authors:  C M MATTHEWS
Journal:  Phys Med Biol       Date:  1957-07       Impact factor: 3.609

3.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

4.  Role of C3b in the breakdown of C3 in hypocomplementaemic mesangiocapillary glomerulonephritis.

Authors:  D G Williams; P J Lachmann; J A Charlesworth; D K Peters
Journal:  Lancet       Date:  1973-03-03       Impact factor: 79.321

5.  Serum C'3 lytic system in patients with glomerulonephritis.

Authors:  R E Spitzer; E H Vallota; J Forristal; E Sudora; A Stitzel; N C Davis; C D West
Journal:  Science       Date:  1969-04-25       Impact factor: 47.728

6.  Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis).

Authors:  R J Pickering; R C Herdman; A F Michael; R L Vernier; H Gewurz; A J Fish; R A Good
Journal:  Medicine (Baltimore)       Date:  1970-05       Impact factor: 1.889

7.  Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation.

Authors:  L G Hunsicker; S Ruddy; C B Carpenter; P H Schur; J P Merrill; H J Müller-Eberhard; K F Austen
Journal:  N Engl J Med       Date:  1972-10-26       Impact factor: 91.245

8.  Complement studies in membrano-proliferative glomerulonephritis.

Authors:  D K Peters; A Martin; A Weinstein; J S Cameron; T M Barratt; C S Ogg; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1972-07       Impact factor: 4.330

9.  Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.

Authors:  M Ballow; C G Cochrane
Journal:  J Immunol       Date:  1969-11       Impact factor: 5.422

10.  Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.

Authors:  C A Alper; F S Rosen
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808
  10 in total
  9 in total

1.  Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation.

Authors:  J G Sissons; J Liebowitch; N Amos; D K Peters
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

2.  C3 metabolism in a patient with deficiency of the second component of complement (C2) and discoid lupus erythematosus.

Authors:  J H Wild; N J Zvaifler; H J Müller-Eberhard; C B Wilson
Journal:  Clin Exp Immunol       Date:  1976-05       Impact factor: 4.330

3.  Complement (C3) metabolism in rheumatoid arthritis in relation to the disease course.

Authors:  A J Swaak; H Han; A van Rooyen; M Pillay; C E Hack
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

4.  Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia.

Authors:  J A Charlesworth; D G Williams; E Sherington; P J Lachmann; D K Peters
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

5.  The kinetics and distribution of C9 and SC5b-9 in vivo: effects of complement activation.

Authors:  J D Greenstein; P W Peake; J A Charlesworth
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

6.  Determination of the half-life of C3 in patients and its relation to the presence of C3-breakdown products and/or circulating immune complexes.

Authors:  A J Swaak; A Hannema; C Vogelaar; F A Boom; L van Es; R van Aalst; L W Statius van Eps
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

7.  Acute local inflammation alters synthesis, distribution, and catabolism of third component of complement (C3) in rabbits.

Authors:  U Manthei; R C Strunk; P C Giclas
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

8.  Complement (C3) metabolism in systemic lupus erythematosus in relation to the disease course.

Authors:  A J Swaak; A van Rooyen; C Vogelaar; M Pillay; E Hack
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

9.  Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.

Authors:  A E Bedwell; C J Elson; S D Carter; P A Dieppe; C W Hutton; R Czudek
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.